why choose us

First received: December 19, 2022

Clinical Trial: A Study Evaluating Safety, Tolerability, and Pharmacokinetics of QRL-101 in Healthy Participants

Study Status: Completed

Recruit Status: RECRUITING

Condition: Healthy Volunteers

Study Type: INTERVENTIONAL


Official Title: A Randomized, Placebo-Controlled, Double-blind, Single Ascending Dose, First in Human Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of QRL-101 in Healthy Participants

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of ascending single doses of QRL-101 in male and female healthy participants.The findings from this study will be used to inform the development of QRL-101 for people living with ALS.

Read more